3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
30
Withdrawn
4
Recruiting
3
Active not recruiting
3
Unknown
2
Terminated
1
No longer available
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
2
Advanced Prostate Cancer
1
Interventions
Docetaxel
21
Radiosurgery
20
Radiotherapy
17
Androgen Antagonists
14
Leuprolide
12
Goserelin
12
bicalutamide
11
Prednisone
9
Gonadotropin-Releasing Hormone
9
Abiraterone Acetate
9
enzalutamide
8
Surveys and Questionnaires
8
Radiotherapy, Intensity-Modulated
8
Brachytherapy
8
Blood Specimen Collection
8
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
7
Triptorelin Pamoate
7
Multiparametric Magnetic Resonance Imaging
7
abiraterone
5
pembrolizumab
4
cabazitaxel
4
Standard of Care
4
Positron Emission Tomography Computed Tomography
4
Metformin
4
Heavy Ion Radiotherapy
4
Flutamide
4
Exercise
4
Estramustine
4
luprolide acetate gel depot
3
darolutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Prostatic Neoplasms
×
radium Ra 223 dichloride
×
Clear all
NCT03458559
2020-11-17
RaRe
Amsterdam UMC, location VUmc
Phase 3
Unknown
402 enrolled
NCT02484339
2016-04-27
α-RT
University Hospital Freiburg
Phase 2
Unknown
274 enrolled